宜搜科技(02550.HK)折讓近15%先舊後新配股淨籌3.38億元
宜搜科技(02550.HK)公布,於7月24日與控股股東Growth Value LTD.及配售代理訂立配售及認購協議,以先舊後新方式配售共6,578.7萬股,相當於認購事項完成後經擴大已發行股份總數約14.6%,每股配售價5.26元,較前收市價6.17元折讓約14.7%。
所得淨額料為約3.38億元,公司預期將運用約50%投資互聯網數字中心資產,約30%投資人工智能技術及應用(側重AIGC)、Web3.0業務(如現實世界資產)及數字內容創作等領域,約20%用作集團營運資金。大股東目前持股約27.66%,完成配售及認購後其持股將降至約23.6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.